artenimol has been researched along with Animal Mammary Carcinoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, R; Dong, J; Guo, X; Han, J; Li, L; Yang, W | 1 |
Habibi, Z; Hassan, ZM; Noori, S; Rezaei, B; Taghikhani, M | 1 |
Gerhardt, TE; Kim, BJ; Lai, HC; Park, JS; Sasaki, T; Singh, NP; Wang, S | 1 |
3 other study(ies) available for artenimol and Animal Mammary Carcinoma
Article | Year |
---|---|
Effect of dihydroartemisinin on epithelial-to-mesenchymal transition in canine mammary tumour cells.
Topics: Animals; Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Cell Movement; Dogs; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Mammary Neoplasms, Animal | 2019 |
Dihydroartemisinin can inhibit calmodulin, calmodulin-dependent phosphodiesterase activity and stimulate cellular immune responses.
Topics: Animals; Antineoplastic Agents; Artemisinins; Calmodulin; Carcinoma, Ductal; Cyclic Nucleotide Phosphodiesterases, Type 1; Erythrocytes; Female; Hypersensitivity, Delayed; Immunity, Cellular; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C | 2010 |
Effects of artemisinin dimers on rat breast cancer cells in vitro and in vivo.
Topics: Alcohols; Animals; Anti-Infective Agents; Antioxidants; Artemisinins; Cell Line, Tumor; Dimerization; Female; Humans; In Vitro Techniques; Inhibitory Concentration 50; Mammary Neoplasms, Animal; Models, Chemical; Rats; Rats, Inbred F344; Time Factors | 2011 |